News | November 18, 2024
Richard Manning provided trial testimony that contributed to a decisive legal victory for biotech startup Inhibrx in a $460 million trade secrets case brought by I-Mab Biopharma in Delaware federal district court.
April 12, 2023
Secretariat welcomes Managing Director Fred Selck, Ph.D., to the firm’s Economics practice based in Washington, D.C. Highly regarded for his work at the intersection of healthcare and economics, Dr. Selck joins a rapidly growing team of more than 100 economists, including nearly 50 Ph.D.’s and a practice that has added new capabilities through the firm’s recent addition of economic consulting firm Intensity.
Dr. Selck brings extensive experience in health economics, applied economics, innovation, and intellectual property. He has leveraged this expertise to answer questions related to asset valuation, commercial reasonableness, market definition, competition, and class certification. Dr. Selck has provided analysis and testimony in a wide range of complex healthcare and life sciences matters as part of more than a decade of experience as a consulting and testifying expert. He has testified in U.S. District Court, U.S. Bankruptcy Court, and the Delaware Court of Chancery.
“Dr. Selck’s rich background in the economics of healthcare, insurance, and healthcare policy — in addition to his academic strengths — are a wonderful addition to our team and a benefit to our clients,” said Managing Director Ryan Sullivan. “This is an area of litigation consulting that we are thrilled to expand and I look forward to tackling complex challenges together.”
Secretariat Managing Director Don Harvey added, “In the ever-growing market of complex healthcare litigation, Dr. Selck’s expertise is a unique addition that will benefit our clients tremendously. His knowledge and skills are best in class, and I am thrilled to welcome him to Secretariat as part of our Economics team.”
“I am pleased to begin this new chapter of my career with Secretariat and the outstanding economists in D.C. and across the firm,” Dr. Selck stated, “Secretariat is well-regarded for its consulting work in healthcare and life sciences matters. I look forward to working alongside this exceptional team.”
Prior to Secretariat, Dr. Selck was a Partner at Bates White where his life sciences and healthcare expertise were applied to a wide variety of matters that included patent infringement, antitrust, False Claims Act, and fraudulent conveyance claims. Previously, he was a fellow at the National Center for Health Statistics and part of the Health Economics Research Group at the Centers for Disease Control and Prevention.
Dr. Selck is a member of the Professional Faculty in Health Economics and Health Finance at Johns Hopkins University, where he teaches graduate-level courses in health economics, innovation, and healthcare finance. Further, his work has been published in peer-reviewed journals such as Health Services Research, Journal of Public Health Management and Practice, Statistics in Medicine, and Annals of Surgery.
Dr. Selck earned his Ph.D. in Applied Economics from Johns Hopkins University. He received his master’s and bachelor’s degrees in Economics from City University of New York, Hunter College.
Richard Manning provided trial testimony that contributed to a decisive legal victory for biotech startup Inhibrx in a $460 million trade secrets case brought by I-Mab Biopharma in Delaware federal district court.
Under Dr. Guyer’s leadership, the new Engineering & Scientific Consulting practice will provide the critical research, analysis, and investigations expertise necessary to solve the challenging science, engineering, and regulatory questions behind why products fail and the implications for stakeholders.
The US Music Industries: Jobs & Benefits — 2024 Report
Robert Stoner and Jéssica Dutra have recently published The U.S. Music Industries: Jobs & Benefits—2024 Report for the Recording Industry Association of America where we measure the music industries’ economic impact nationwide, which overall contribute $212 billion to the GDP and account for 2.5 million jobs.